- In a niche field of online therapy through texts, phones calls, video calls, and more
- MedTech industry is a HUGE and rapidly evolving industry over the coming years
- Trading at 11x 2021 Rev. which is half the evaluation to similar companies (a third to some)
- 65% CAGR (more than similar companies by a significant amount)
- B2C and B2B (could see every company having to cover mental healthcare costs of employees soon)
- I would get into the mental health stats but it is pretty obvious depression has ramped up tremendously with smartphones, coronavirus, our head political figures, etc.
- $500B TAM, 25M Rev, 69% YoY growth, 64% gross margins for 2021
- 46,000 active member almost 70% saw improved symptoms (obviously this won’t work for everyone)
- Management team is STACKED
- Literally every stat points that this is more efficient than in person therapy (timeliness, cost is cheaper, convenience, double secondary visit rate, etc.)
- MICHAEL PHELPS AND DEMI LAVATO are the faces of the company = $
- Work with Google, Black Stone, Cigna, etc. and there b2b model is just getting started = $
- Global expansion would blow this off the roof, therapy is becoming more common/accepted = $
- I could talk about this company forever it is an absolute no brainer and you are investing in helping people improve their mental health/lives, would love to see a bear case on this so I can screenshot it
I predict this will be picked up by Ark in the future, if not it would be a huge missed opportunity. Could get acquired by Teledoc. Just broke out of a downward trend on Friday and is extremely under the radar if looking to start a position.
Anything I missed?